CHMMF vs GILD: Which Stock is Better?

Side-by-side comparison of Chimeric Therapeutics Limited and Gilead Sciences Inc in 2026

Comparison Updated:

CHMMF

Chimeric Therapeutics Limited

GILD

Gilead Sciences Inc

$136.36

Key Metrics Comparison

MetricCHMMFGILDWinner
Market Cap$5.18M$160.15BGILD
P/E RatioN/A17.55GILD
EPS (TTM)$N/A$N/ATie
Revenue Growth0.0%0.0%Tie
Gross Margin0.0%0.0%Tie

Analyze CHMMF

Full quant analysis

Analyze GILD

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is CHMMF or GILD a better investment?

Comparing CHMMF and GILD: Chimeric Therapeutics Limited has a market cap of $5.18M while Gilead Sciences Inc has $160.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between CHMMF and GILD?

CHMMF (Chimeric Therapeutics Limited) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: CHMMF or GILD?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: CHMMF or GILD?

Both CHMMF and GILD show similar growth rates. Check our detailed analysis for quarterly trends.

Which company is more profitable: CHMMF or GILD?

Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.

Which is the larger company: CHMMF or GILD?

Gilead Sciences Inc (GILD) is larger with a market cap of $160.15B compared to $5.18M for CHMMF.

Should I buy CHMMF or GILD in 2026?

Both CHMMF and GILD have investment merit. CHMMF trades at $N/A while GILD trades at $136.36. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between CHMMF and GILD stock?

Key differences: Market Cap ($5.18M vs $160.15B), P/E Ratio (N/A vs 17.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).

Should I buy CHMMF or GILD in 2026?

The choice between CHMMF and GILD depends on your investment goals. GILD shows higher revenue growth (0.0%). GILD has better margins (0.0%). Consider your risk tolerance and time horizon.

What is the market cap comparison between CHMMF and GILD?

CHMMF (Chimeric Therapeutics Limited) has a market cap of $5.18M, while GILD (Gilead Sciences Inc) has a market cap of $160.15B. GILD is the larger company by market value.

Popular Stock Comparisons